GoHealth, Inc. (NASDAQ:GOCO – Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 129,400 shares, a decline of 8.7% from the December 31st total of 141,700 shares. Based on an average daily volume of 38,900 shares, the days-to-cover ratio is presently 3.3 days. Currently, 1.6% of the company’s shares are sold short.
Hedge Funds Weigh In On GoHealth
A number of large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC raised its holdings in shares of GoHealth by 3.2% in the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock valued at $973,000 after purchasing an additional 3,205 shares during the period. Empowered Funds LLC lifted its holdings in shares of GoHealth by 5.3% during the 4th quarter. Empowered Funds LLC now owns 23,218 shares of the company’s stock worth $311,000 after acquiring an additional 1,170 shares during the period. Renaissance Technologies LLC boosted its stake in GoHealth by 22.0% in the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock valued at $178,000 after buying an additional 3,300 shares in the last quarter. Barclays PLC grew its stake in shares of GoHealth by 83.9% during the third quarter. Barclays PLC now owns 9,580 shares of the company’s stock worth $89,000 after buying an additional 4,372 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in GoHealth by 99.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 8,437 shares of the company’s stock valued at $79,000 after buying an additional 4,204 shares during the last quarter. Institutional investors own 24.21% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada reissued a “sector perform” rating and set a $13.00 price target on shares of GoHealth in a research report on Monday, October 21st.
GoHealth Price Performance
Shares of GOCO traded down $0.04 during mid-day trading on Monday, hitting $16.26. The company’s stock had a trading volume of 13,373 shares, compared to its average volume of 61,737. GoHealth has a fifty-two week low of $7.27 and a fifty-two week high of $18.20. The company has a debt-to-equity ratio of 1.72, a current ratio of 1.18 and a quick ratio of 1.18. The stock has a market capitalization of $372.45 million, a price-to-earnings ratio of -4.65 and a beta of 1.64. The firm has a 50-day moving average price of $13.43 and a 200 day moving average price of $11.42.
GoHealth (NASDAQ:GOCO – Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($3.73) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.19) by ($0.54). The business had revenue of $118.29 million during the quarter, compared to the consensus estimate of $105.93 million. GoHealth had a negative net margin of 4.32% and a negative return on equity of 17.17%. During the same period in the previous year, the firm earned ($2.61) EPS. On average, research analysts predict that GoHealth will post -5.5 EPS for the current fiscal year.
GoHealth Company Profile
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
Featured Articles
- Five stocks we like better than GoHealth
- Using the MarketBeat Stock Split Calculator
- How to Invest in Small Cap Stocks
- How to Short a Stock in 5 Easy Steps
- These Are the Dividend Stocks Insiders Bought in January
- What is the S&P/TSX Index?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.